Nanjing King-Friend Biochemical Pharmaceutical (603707.SHG) Q3 2026 Earnings

1SepConfirmed
Q3 2025
Q4 2025
Q2 2026
0.05
0.11
0.18
0.24

Details

Expected EPS
0.1499319
Actual EPS
N/A
Surprise EPS
-0.15
Surprise Percent
+100%

Description

Nanjing King-Friend Biochemical Pharmaceutical (603707.SHG) will report earnings of for Q3 2026 on September 01, 2026.

0 Comments

Share your thoughts